(Q79137459)
Statements
Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy (English)
George Dranitsaris
Wei S Ooi
Geetha Yogendran
Tatjana Sukovic
Betty Y L Wong
Sunil Verma
Kathleen I Pritchard
Maureen Trudeau
David E C Cole
25 September 2006